Recommendations of the American association of physicists in medicine on 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription

Medical Physics

Volumn 27, Issue 4, 2000, Pages 634-642

  Williamson, Jeffrey F ^a,h   Coursey, Bert M ^b   DeWerd, Larry A ^c   Hanson, William F ^d   Nath, Ravinder ^e   Rivard, Mark J ^f   Ibbott, Geoffrey ^g  

^a WASHINGTON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

103Pd brachytherapy; Air kerma strength; Dose prescriptions

Indexed keywords

DOSIMETRY; RATE CONSTANTS;

AIR KERMA; BRACHYTHERAPY; CALIBRATION PROCEDURE; CALIBRATION STANDARD; DOSE PRESCRIPTION; NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY; RADIATION ONCOLOGISTS; TREATMENT PLANNING SYSTEMS;

CALIBRATION;

CADMIUM 109; PALLADIUM; PALLADIUM 103; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CANCER RADIOTHERAPY; DOSE CALCULATION; DOSIMETRY; INTERSTITIAL RADIATION; PRIORITY JOURNAL; STANDARD;

EID: 0034004512     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.598923     Document Type: Article

References (23)

1. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, R. Nath, and G. Ibbott, "Guidance to users of Nycomed Amersham and North American Scientific, Inc. I-125 Interstitial Sources: Dosimetry and calibration changes: Recommendation of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry," Med. Phys. 26, 570-573 (1999).
2. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43," Med. Phys 22, 209-234 (1995).
3. A. S. Meigooni, S. Sabnis, and R. Nath, "Dosimetry of palladium-103 brachytherapy sources for permanent implants," Endocurietherapy/ Hyperthermia Oncology 6, 107-117 (1990).
4. 103Pd seeds (model 200) in solid water phantom," Med. Phys. 18, 449-452 (1991).
5. R. Loevinger, "Wide-angle free-air chamber for calibration of low-energy brachytherapy sources," Med. Phys. 20, 907 (abstract) (1993)
6. S. M. Seltzer, P. J. Lamperti, R. Loevinger, C. G. Soares, and J. T. Weaver, "New NIST air-kerma strength standards for 1-125 and Pd-103 brachytherapy seeds (abstract)," Med. Phys. 25, 170 (1998).
7. 103Pd Therapy Seeds Based on the Wide-Angle Free-Air Chamber (WAFAC): Proceedings of a CIRMS Workshop, National Institute of Standards and Technology, 1999.
8. B. M. Coursey, Model 200 Air-Kerma Calibration, personal communication, November 1999, National Institutes of Standards and Technology. Ionizing Radiation Division, Gaithersburg, MD.
9. M. C. Jacobs, letter to its customers, Personal Communication, 15 October 1997, Theragenics Corporation.
10. T. Robin and J. Rodgers, Theragenics Cd-109 Source Change History - Theraseed® Model 200, personal communication, 30 August 1999, Theragenics Corporation, Buford, GA.
11. Z. Li, "Monte Carlo calculations and experimental measurements of dosimetry parameters of a new Pd-103 source." Report to North American Scientific, Inc., Radiation Oncology, University of Florida, 1999.
12. 103palladium brachytherapy source," Med. Phys. 26, 2465-2470 (1999).
13. 103Pd seeds with air-kerma strength calibration based upon a primary national standard," Med. Phys. 27, 655-658 (2000).
14. 103Pd interstitial brachytherapy source," Med. Phys. 27, 643-654 (2000).
15. T. P. Loftus, "Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy," J. Res. Natl. Bur. Stand. 89, 295-303 (1984).
16. S. Y. F. Chu, L. P. Ekström, and R. B. Firestone, "WWW Table of Radioactive Isotopes, database version 2/28/99 from URL http:// nucleardata.nuclear.lu.se/nucleardata/toi/"
17. 103Pd interstitial brachytherapy sources: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Subcommittee on Low-Energy Brachytherapy Source Dosimetry," Med. Phys. 26, 2529-2530 (1999).
18. E. E. Furhang and L. L. Anderson, "Functional fitting of interstitial brachytherapy dosimetry data recommended by AAPM Radiation Therapy Committee Task Group 43," Med. Phys. 26, 153-160 (1999).
19. 103Pd sources," Med. Phys. 25, 2271-2278 (1998).
20. W. S. Bice, B. R. Prestidge, J. J. Prete, and D. F. Dubois, "Clinical impact of implementing AAPM Task Group 43 on permanent prostate brachytherapy using I-125," Int. J. Radiat. Oncol., Biol., Phys. 40, 1237-1241 (1998).
21. 103Pd brachytherapy and external beam irradiation for clinically-localized, high-risk prostatic carcinoma," Int. J. Radiat. Oncol., Biol., Phys. 35, 875-879 (1996).
22. R. G. Stock, N. N. Stone, J. K. DeWyngaert, P. Lavagnini, and P. D. Unger, "Prostate specific antigen findings and biopsy results following interactive ultrasound-guided transperineal brachytherapy for early stage prostate carcinoma," Cancer 77, 2386-2392 (1996).
23. L. L. Anderson, J. V. Moni, and L. B. Harrison, "A nomograph for permanent implants of palladium-103 seeds," Int. J. Radiat. Oncol., Biol., Phys. 27, 129-135 (1993).